Author

Janet Sue Rader

Medical College of WisconsinORCID 0000-0001-7031-3385Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Akinyemi I. OjesinaiD· 2 shared Ishaque Pulikkal Kadamberi· 2 shared Marissa IdeniD· 2 shared Rachel Schmidt· 2 shared Shirng‐Wern TsaihiD· 2 shared William Hampton BradleyiD· 2 shared A. Nair· 1 shared Ajay Nair· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Akinyemi I. OjesinaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 6, 2026

TAOK3 inhibition constrains invasion, potentiates paclitaxel, and reprograms the tumor microenvironment toward anti-tumor immunity in cervical cancer

Marissa Iden, Rachel Schmidt, Rameesa Darul Amne Syed Mohammed…·Janet Sue Rader

This study shows TAOK3 inhibition reduces cervical cancer invasion, increases paclitaxel sensitivity, and promotes anti-tumor immunity by altering the tumor microenvironment.

DOI 10.64898/2026.07.04.736128

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 9, 2026

MRPL47 as a Novel Mitochondrial Biomarker for Early Detection and Therapeutic Response in Ovarian Cancer

Meenakshi Pradeep, Ishaque Pulikkal Kadamberi, Jasmine George…·Akinyemi I. Ojesina

This study identifies MRPL47 as a biomarker for ovarian cancer, showing its association with poor survival, metabolic changes, and therapeutic response.

DOI 10.64898/2026.03.05.709884

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsGenome ResearchPeer-reviewedApr 1, 2025

Genomic structures and regulation patterns at HPV integration sites in cervical cancer

Vanessa Porter, Michelle Ng, Kieran O’Neill…·Marco A. Marra

The paper uses long-read sequencing to analyze HPV integration sites in cervical cancer genomes, identifying structural and epigenetic impacts of integration.

13 citations

humanwhole-genome sequencing

𝕏 PostBluesky